From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma
Group
n
Expression of NMU
Low
High
Peri-tumor
228
133 (58.3%)
95 (41.7%)
Intra-tumor
137 (60.1%)
91 (39.9%)